Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - A double-blind, randomized, placebo-controlled trial

Metabolism: Clinical and Experimental

Volumn 63, Issue 9, 2014, Pages 1115-1124

  Kampmann, Ulla ^a   Mosekilde, Leif ^a   Juhl, Claus ^c   Moller, Niels ^a   Christensen, Britt ^a   Rejnmark, Lars ^a   Wamberg, Louise ^c   Orskov, Lotte ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b SILKEBORG REGIONAL HOSPITAL   (Denmark)

^c ESBJERG HOSPITAL   (Denmark)

Author keywords

Hyperinsulinemic euglycemic clamp; Inflammation; Insulin pulsatility; Vitamin D deficiency

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; C PEPTIDE; COLECALCIFEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; METFORMIN; NEUTRAL INSULIN; PLACEBO;

ADULT; AGED; ARTICLE; BACKACHE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIFFERENTIAL SCANNING CALORIMETRY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG OVERDOSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

HYPERINSULINEMIC EUGLYCEMIC CLAMP; INFLAMMATION; INSULIN PULSATILITY; VITAMIN D DEFICIENCY;

AGED; BIOLOGICAL MARKERS; C-PEPTIDE; CALCIFEDIOL; CALCITRIOL; CHOLECALCIFEROL; DENMARK; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; KINETICS; MALE; MIDDLE AGED; SEASONS; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 84906271657     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.06.008     Document Type: Article

References (49)

1. M. Holick Diabetes and the vitamin D connection Curr Diab Rep 8 2008 393 398
2. E. Hypponen, E. Laara, and A. Reunanen et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 2001 1500 1503
3. The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus Diabetologia 42 1999 51 54
4. L.C. Stene, J. Ulriksen, and P. Magnus et al. Use of cod liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring Diabetologia 43 2000 1093 1098
5. A.G. Pittas, B. Dawson-Hughes, and T. Li et al. Vitamin D and calcium intake in relation to type 2 diabetes in women Diabetes Care 29 2006 650 656
6. R. Scragg, M. Sowers, and C. Bell Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey Diabetes Care 27 2004 2813 2818
7. K.C. Chiu, A. Chu, and V.L. Go et al. Hypovitaminosis D is associated with insulin resistance and beta-cell dysfunction Am J Clin Nutr 79 2004 820 825
8. N.G. Forouhi, J. Luan, and A. Cooper et al. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000 Diabetes 57 2008 2619 2625
9. O. Gedik, and S. Akalin Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man Diabetologia 29 1986 142 145
10. L. Lind, T. Pollare, and A. Hvarfner et al. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure Diabetes Res 11 1989 141 147
11. 3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients Int J Clin Pract 57 2003 258 261
12. A.G. Pittas, P.C. Stark, and S.S. Harris et al. The effects of calcium and vitamin D supplementation on blood glucose and markers and inflammation in nondiabetic adults Diabetes Care 30 2007 980 986
13. 3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men Diabet Med 26 2009 19 27
14. P. Von Hurst, W. Stonehouse, and J. Coad Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomized, placebo-controlled trial Br J Nutr 103 2009 549 555
15. C. Luo, J. Wong, and M. Brown et al. Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation Diab Vasc Dis Res 6 2009 194 199
16. R. Jorde, and Y. Figenschau Supplementation with cholecalciferol does not improve glycemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels Eur J Nutr 48 2009 349 354
17. G. Grimnes, Y. Figenschau, and B. Almås et al. Vitamin D, insulin secretion, sensitivity, and lipids Diabetes 60 11 2011 2748 2757
18. J. Mitri, B. Dawson-Hughes, and F. Hu et al. Am J Clin Nutr 94 2011 486 494
19. N.M. Al-Daghri, K.M. Alkharfy, and Y. Al-Saleh et al. Modest reversal of metabolic syndrome manifestations with vitamin D correction: a 12-month prospective study Metabolism 61 2012 661 666
20. A.G. Pittas, M. Chung, and T. Trikalinos et al. Vitamin D and cardiometabolic outcomes: a systematic review Ann Intern Med 152 2010 307 314
21. J. Parker, O. Hashmi, and A. Mavrodaris et al. Levels of vitamin D and cardiometabolic syndrome: systematic review and metaanalysis Maturitas 65 2010 225 236
22. Fuleihan G. El-Hajj Can the sunshine vitamin melt the fat? Metabolism 61 2012 603 610
23. J. Alvarez, and A. Ashraf Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis Int J Endocrinol 2010 2010 1 18 [Article ID 351385]
24. M. Cigolini, M.P. Iagulli, and V. Miconi et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients Diabetes Care 29 2006 722 724
25. L. Lind, A. Hanni, and H. Lithell et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men Am J Hypertens 8 1995 894 901
26. L. Mosekilde Vitamin D, and the elderly Clin Endocrinol 62 2005 265 281
27. N. Pørksen, S. Munn, and J. Steers et al. Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting Am J Physiol 269 1995 E478 E488
28. J.D. Veldhuis, M.L. Carlson, and M.L. Johnson The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous mutiple-parameter deconvolution of plasma hormone concentrations Proc Natl Acad Sci U S A 84 1987 7686 7690
29. N.K. Pørksen, B. Nyholm, and J.D. Veldhuis et al. In humans at least 75% of insulin secretion arises from punctuated secretory bursts Am J Physiol 273 1997 E908 E914
30. C. Chatfield The analysis of time series An introduction 5th ed. 1996 Chapman and Hall London
31. C.B. Juhl, O. Schmitz, S.M. Pincus, and J.J. Holst et al. Short-term treatment with GLP-1increases pulsatile insulin secretion in type II diabetes with no effect on orderliness Diabetologia 43 2000 583 588
32. C.B. Juhl, N. Pørksen, and M. Hollingdal et al. Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency Diabetes Care 23 2000 675 681
33. S.M. Pincus Approximate entropy as a measure of system complexity Proc Natl Acad Sci U S A 88 1991 2297 2301
34. S.M. Pincus, M.L. Hartman, and F. Roelfsema et al. Hormone pulsatility discrimination via coarse and short time-sampling Am J Physiol 277 1999 E948 E957
35. D. Tripathy, Y. Wessman, and M. Gullstrom et al. Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp Diabetes Care 26 2003 1395 1401
36. H. Orskov, H.G. Thomsen, and H. Yde Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone Nature 219 1968 193 195
37. S. Kadowaki, and A.W. Norman Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas J Clin Invest 73 1984 759 766
38. C. Cade, and A.W. Norman Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo Endocrinology 119 1986 84 90
39. 3 on markers of vascular health in patients with type 2 diabetes: a randomized controlled trial Diabetologia 53 2010 2112 2119
40. J.A. Johnson, J.P. Grande, and P.C. Roche et al. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas Am J Physiol 267 1994 E356 E360
41. U. Zeitz, K. Weber, and D.W. Soegiarto et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor FASEB J 17 2003 509 511
42. I.N. Sergeev, and W.B. Rhoten 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line Endocrinology 136 1995 2852 2861
43. J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 2004 813 823
44. D. Scarpelli, M. Cardellini, and F. Andreozzi et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects Diabetes 55 2006 1529 1533
45. D.L. Kamen, and V. Tangpricha Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity J Mol Med 88 2010 441 450
46. E.B. Geer, and W. Shen Gender differences in insulin resistance, body composition and energy balance Gend Med 6 2009 60 75
47. J.J. Meier, C. Pennartz, and N. Schenker et al. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy Diabetes Obes Metab 15 2013 258 263
48. C.B. Juhl, J. Gjedsted, and M.F. Nielsen et al. Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans Metabolism 61 2012 1177 1181
49. M. Hollingdahl, J. Sturis, and M.A. Gall et al. Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in type 2 diabetes Diabet Med 22 2005 1408 1413